HIMS
Hims & Hers Health·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 8
Bearish signal 1
Stock Price Surged Significantly
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Gap Up
Significant Net Income Decline
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About HIMS
Hims & Hers Health, Inc.
A provider of health care software solutions and health and wellness products in the United States
Healthcare Providers and Services
12/30/2013
09/13/2019
New York Stock Exchange
1,637
12-31
Common stock
2269 Chestnut Street, #523 San Francisco, California 94123
--
Hims & Hers Health, Inc., was incorporated as a Delaware corporation on December 30, 2013. Their mission is to make health care affordable and convenient for all. They designed and built cloud-based digital native technologies with consumers in mind. Their proprietary website, telemedicine platform, electronic medical record system, pharmacy integration and mobile accessibility combine to provide consumers with a seamless, easy-to-use, mobile-first experience.
Earnings Call
Company Financials
EPS
HIMS has released its 2025 Q3 earnings. EPS was reported at 0.06, versus the expected 0.1, missing expectations. The chart below visualizes how HIMS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
HIMS has released its 2025 Q3 earnings report, with revenue of 598.98M, reflecting a YoY change of 49.16%, and net profit of 15.77M, showing a YoY change of -79.13%. The Sankey diagram below clearly presents HIMS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


